Protective role of nitric oxide in ischemia and reperfusion injury of the liver

Journal of the American College of Surgeons

Volumn 188, Issue 1, 1999, Pages 43-52

  Shimamura, Tsuyoshi ^a   Zhu, Yue ^b   Zhang, Shimin ^b   Jin, Maeng Bong ^a   Ishizaki, Naoki ^b   Urakami, Atsushi ^b   Totsuka, Eishi ^b   Kishida, Akihiro ^a   Lee, Randall ^b   Subbotin, Vladimir ^b   Furukawa, Hiroyuki ^a   Starzl, Thomas E ^b   Todo, Satoru ^a,b  

^a HOKKAIDO UNIVERSITY   (Japan)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 ETHYL 2 HYDROXYIMINO 5 NITRO 3 HEXENAMIDE; ARGININE; NITRIC OXIDE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; DRUG EFFECT; DRUG SCREENING; FEMALE; HIGH ENERGY PHOSPHATE; HYPOTENSION; LIVER INJURY; LIVER ISCHEMIA; MORTALITY; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; SURVIVAL;

ADENINE NUCLEOTIDES; ALANINE TRANSAMINASE; ANIMALS; ARGININE; ASPARTATE AMINOTRANSFERASES; BILE ACIDS AND SALTS; DOGS; FEMALE; HYALURONIC ACID; L-LACTATE DEHYDROGENASE; LIVER; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRO COMPOUNDS; REGIONAL BLOOD FLOW; REPERFUSION INJURY;

EID: 0032920350     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(98)00259-2     Document Type: Article

References (46)

1. Todo S, Zhu Y, Zhang S, et al. Attenuation of ischemic liver injury by augmentation of endogenous adenosine. Transplantation 1997;63:217-223.
2. Ishizaki N, Zhu Y, Zhang S, et al. Comparison of various lazaroid compounds for protection against ischemic liver injury. Transplantation 1997;63:202-208.
3. Urakami A, Todo S, Zhu Y, et al. Attenuation of ischemic liver injury by monoclonal anti-endothelin antibody, AwETN40. J Am Coll Surg 1997;185:358-364.
4. Ma TT, Ischiropoulos H, Brass CA. Endotoxin-stimulated nitric oxide production increases injury and reduces rat liver chemiluminescence during reperfusion. Gastroenterology 1995; 108:463-469.
5. Jaeschke H, Schini VB, Farhood A. Role of nitric oxide in the oxidant stress during ischemia/reperfusion injury of the liver. Life Sci 1992;50:1797-1804.
6. Wang Y, Mathews R, Guido DM, et al. Inhibition of nitric oxide synthesis aggravates reperfusion injury after hepatic ischemia and endotoxemia. Shock 1995;4:282-288.
7. Shiraishi M, Hiroyasu S, Nagahama M, et al. Role of exogenous L-arginine in hepatic ischemia-reperfusion injury. J Surg Res 1997;69:429-434.
8. Koeppel TA, Thies JC, Schemmer P, et al. Inhibition of nitric oxide synthesis in ischemia and reperfusion of the rat liver is followed by impairment of hepatic microvascular blood flow. J Hepatol 1997;27:163-169.
9. Hino M, Iwaki M, Okamoto M, et al. FK409, a novel vasodilator isolated from the acid-treated fermentation broth of streptomyces griseosporeus. J Antibiot (Tokyo) 1989;42:1578-1583.
10. Mashige F, Imai K, OsugaT. A simple and sensitive assay of total serum bile acids. Clin Chim Acta 1976;70:79-86.
11. Chichibu K, Matsuura T, Shichijo S, Yokoyama MM. Assay of serum hyaluronic acid in clinical application. Clin Chim Acta 1989;181:317-324.
12. Hamamoto I, Takaya S, Todo S, et al. Can adenine nucleotides predict primary nonfunction of the human liver homograft? Transplant Int 1994;7:89-95.
13. Atkinson DE. The energy charge of the adenylate pool as a regulatory parameter: interaction with feedback modifiers. Biochemistry 1968;7:4030-4034.
14. Stevens A. Enzyme histochemistry: diagnostic applications. In: Bancroft JD, Stevens A, eds. Theory and Practice of Histological Techniques. New York: Churchill Livingstone; 1990:401-411.
15. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988;333: 664-666.
16. Dinerman JL, Lowenstein CJ, Snyder SH. Molecular mechanisms of nitric oxide regulation. Potential relevance to cardiovascular disease. Circ Res 1993;73:217-222.
17. Back KJ, Thiel BA, Lucas S, Stuehr DJ. Macrophage nitric oxide synthase subunits. J Biol Chem 1993;268:21120-21129.
18. Nussler AK, Billiar TR. Inflammation, immunoregulation, and inducible nitric oxide synthase. J Leukoc Biol 1993;54:171-178.
19. Rapoport RM, Murad F. Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMP. Circ Res 1983;52:352-357.
20. Radamoski MW, Palmer RMJ. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987;ii:1057-1058.
21. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991;88:4651-4655.
22. Davenpeck KL, Gauthier TW, Lefer AM. Inhibition of endothelil-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation. Gastroenterology 1994; 107:1050-1058.
23. Harbrecht BG, Wang SC, Simmons RL, Billiar TR. Cyclic GMP and guanylate cyclase mediate lipopolysaccharide-induced Kupffer cell tumor necrosis factor-a synthesis. J Leukoc Biol 1995;57:297-302.
24. Kawada N, Tran-thi TA, Klein H, Decker K. The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus. Eur J Biochem 1993; 213:815-823.
25. Tsao PS, Lefer AM. Time course and mechanism of endothelial dysfunction in isolated ischemic-and hypoxic-perfused rat hearts. Am J Physiol 1990;259:H1660-1666.
26. Langle F, Steininger R, Waldmann E, et al. Improvement of cardiac output and liver blood flow and reduction of pulmonary vascular resistance by intravenous infusion of L-arginine during the early reperfusion period in pig liver transplantation. Transplantation 1997;63:1225-1233.
27. Rees D, Palmer M, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 1989;86:3375-3378.
28. Girerd XJ, Hirsch AT, Cooke JP, et al. L-arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits. Circ Res 1990;67:1301-1308.
29. Fineman J, Chang R, Soifer S. L-arginine, a precursor of EDRF in vivo, produces pulmonary vasodilation in lambs. Am J Physiol 1991;261:H1563-1569.
30. Kakumitsu S, Shijo H, Yokoyama M, et al. Effect of L-arginine on the systemic, mesenteric, and hepatic circulation in patients with cirrhosis. Hepatology 1998;27:377-382.
31. Huk I, Nanobashvili J, Neumayer C, et al. L-arginine treatment alters the kinetics of nitric oxide and superoxide release and reduces ischemia/reperfusion injury in skeletal muscle. Circulation 1997;96:667-675.
32. Palmer JP, Walter RM, Ensick JW. Arginine-stimulated acute phase of insulin and glucagon secretion: I. In normal man. Diabetes 1975;24:735-740.
33. Weyrich AS, Ma XL, Lefer AM. The role of L-arginine in amelio-rating reperfusion injury after myocardial ischemia in the cat. Circulation 1992;86:279-288.
34. Fukuyama S, Kita Y, Hirasawa Y, et al. A new nitric oxide (NO) releaser: spontaneous NO release from FK409. Free Radic Res 1995;23:443-452.
35. Isono T, Sato N, Yamamoto T, et al. Tolerance to the vascular effect of a novel nitric oxide-donating vasodilator, FK409. Eur J Pharmacol 1994;260:163-168.
36. Aisaka K, Gross S, Griffith O, Levi R. NG-methyl-L-arginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: does nitric oxide regulate blood pressure in vivo? Biochem Biophys Res Commun 1989; 160:881-886.
37. Feletou M, Hoeffner U, Vanhoutte P. Endothelium-derived relaxing factors do not affect the smooth muscle of portal-mesenteric veins. Blood Vessels 1989;26:21-32.
38. Kourembanas S, McQuillan LP, Leung GK, Faller DV. Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J Clin Invest 1993;92:99-104.
39. Hotter G, Closa D, Pi F, et al. Nitric oxide and arachidonate metabolism in ischemia-reperfusion associated with pancreas transplantation. Transplantation 1995;59:417-421.
40. Granger DN. Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury. Am J Physiol 1988;255: H1269-H1275.
41. McCall T, Whittle BJR, Boughton-Smith NK, Moncada S. Inhibition of FMLP-induced aggregation of rabbit neutrophils by nitric oxide [abstract]. Br J Pharmacol 1988;95:517P.
42. Lefer DJ, Nakanishi K, Johnston WE, Vinten-Johansen J. Antineutrophil and myocardial protecting actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion in dogs. Circulation 1993;88:2337-2350.
43. Beckman JS, Beckman TW, Chen J, et al. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990;87:1620-1624.
44. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 1991; 2:481-487.
45. Stuehr DJ, Nathan CF. Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor cells. J Exp Med 1989;169:1543-1555.
46. Stadler J, Billiar TR, Curran RD, et al. Effect of endogenous and exogenous nitric oxide on mitochondrial respiration of rat hepatocytes. Am J Physiol 1991;260:C910-C916.